Education
About Us
Working with TipRanks
Follow Us
Bio-Key International (BKYI)
NASDAQ:BKYI
BKYI Stock Chart & Stats
$0.88
-$0.29(-17.16%)
At close: 4:00 PM EST
$0.88
-$0.29(-17.16%)
Day’s Range― - ―
52-Week Range$0.61 - $3.68
Previous CloseN/A
Volume225.68K
Average Volume (3M)1.84M
Market Cap
$6.83M
Enterprise Value$4.17M
Total Cash (Recent Filing)$2.04M
Total Debt (Recent Filing)$1.46M
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Mar 26, 2026EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding10,836,618
10 Day Avg. Volume253,174
30 Day Avg. Volume1,838,410
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.75
Price to Sales (P/S)0.95
P/FCF Ratio-2.26
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit0.84
Enterprise Value/Ebitda-1.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.5
Revenue Forecast (FY)$7.30M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement continues to expect sequential revenue growth and improved profitability in 2025.
Product InnovationBKYI recently entered the passkey authentication market with the launch of 'Passkey:YOU', a unique password-less authentication solution.
Sales StrategyBKYI is building a military- and intelligence-focused global sales team targeting the growing EU defense opportunity.
Bears Say
Brand Strategy ShiftResults were below expectations due to an intentional shift away from its Swivel Secure brand to focus on core Bio-Key branded solutions.
BIO-key International News
BKYI FAQ
What was Bio-Key International’s price range in the past 12 months?
Bio-Key International lowest stock price was $0.61 and its highest was $3.68 in the past 12 months.
What is Bio-Key International’s market cap?
Bio-Key International’s market cap is $6.83M.
When is Bio-Key International’s upcoming earnings report date?
Bio-Key International’s upcoming earnings report date is Mar 26, 2026 which is in 91 days.
How were Bio-Key International’s earnings last quarter?
Bio-Key International released its earnings results on Nov 14, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.12 by -$0.03.
Is Bio-Key International overvalued?
According to Wall Street analysts Bio-Key International’s price is currently Overvalued.
Does Bio-Key International pay dividends?
Bio-Key International does not currently pay dividends.
What is Bio-Key International’s EPS estimate?
Bio-Key International’s EPS estimate is -0.07.
How many shares outstanding does Bio-Key International have?
Bio-Key International has 10,836,618 shares outstanding.
What happened to Bio-Key International’s price movement after its last earnings report?
Bio-Key International reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.12. Following the earnings report the stock price went down -2.062%.
Which hedge fund is a major shareholder of Bio-Key International?
Currently, no hedge funds are holding shares in BKYI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio-Key International
BIO-key International (BKYI) is a provider of biometric identification and authentication solutions, specializing in secure access management for businesses and government entities. The company operates primarily in the cybersecurity sector, offering a range of products that include fingerprint biometric scanners, identity management software, and mobile biometric solutions. BIO-key's technology is designed to enhance security, streamline user authentication processes, and improve operational efficiency across various industries.
BKYI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a company with promising growth opportunities, particularly in the defense sector, and strong customer retention, evidenced by high renewal rates. However, current financial challenges, such as declining quarterly revenue and increased net loss, are notable concerns. The company's efforts to manage costs and its pipeline of new and renewed contracts provide optimism for future performance.View all BKYI earnings summariesTechnical Analysis
Ownership Overview
3.73% Insiders
0.60% Mutual Funds
0.27% Other Institutional Investors
95.08% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---